SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 109.38 |
Enterprise Value ($M) | 137.41 |
Book Value ($M) | 13.15 |
Book Value / Share | 0.25 |
Price / Book | 8.32 |
NCAV ($M) | 11.57 |
NCAV / Share | 0.22 |
Price / NCAV | 9.45 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.61 |
Return on Assets (ROA) | -0.55 |
Return on Equity (ROE) | -2.48 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 9.10 |
Current Ratio | 9.10 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 73.93 |
Assets | 75.50 |
Liabilities | 62.35 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | -42.10 |
Net Income | -41.52 |
Earnings Per Share Basic And Diluted | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -28.85 |
Cash from Investing | 8.28 |
Cash from Financing | 32.12 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Rtw Investments, Lp | 9.99 | 68.13 | |
13G/A | BlackRock, Inc. | 7.60 | 23.85 | |
13G/A | Integrated Core Strategies (us) Llc | 5.20 | 60.53 | |
13D/A | Alta Fundamental Advisers LLC | 4.99 | 59.07 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
1,121,457 | 3,026,437 | 37.06 | |
1,010,742 | 3,337,588 | 30.28 | |
850,680 | 2,172,727 | 39.15 | |
(click for more detail) |
Similar Companies | |
---|---|
MDGL – Madrigal Pharmaceuticals, Inc. | MGNX – MacroGenics, Inc. |
MGTX – MeiraGTx Holdings plc | MLYS – Mineralys Therapeutics, Inc. |
MNMD – Mind Medicine (MindMed) Inc. |
Financial data and stock pages provided by
Fintel.io